Post by PressReleaseon Sep 28, 2022 9:25am
32 Views
Post# 34991763
New Press Release - Medicenna Reports Confirmed Partial Response in Pancreatic Cancer and Clinical Update on MDNA11's Monotherapy Dose Escalation Portion of the Ongoing Phase 1/2 ABILITY Study